SCHEMBL6544479

SCHEMBL6544479

Cn1c(CO)nc2ccc(Oc3c(F)c(F)c(F)c(F)c3F)cc21

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.50
ESRRA P11474 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487370 0.85 PPARG (0.60) PPARG
SCHEMBL3486572 0.84 PPARG (0.61) PPARGESRRA
SCHEMBL3488145 0.84 PPARG (0.61) PPARGESRRA
SCHEMBL3487158 0.82 PPARG (0.66) PPARG
SCHEMBL3487083 0.82 PPARG (0.62) PPARGESRRA
SCHEMBL3487226 0.82 PPARG (0.62) PPARG
SCHEMBL3487449 0.81 PPARG (0.59) PPARGESRRA
SCHEMBL3487134 0.81 PPARG (0.59) PPARGESRRA
SCHEMBL3486865 0.81 PPARG (0.63) PPARGESRRA
SCHEMBL3488585 0.81 PPARG (0.63) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed